FO
ICPT

FT Options’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

FT Options’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$1.18M Buy
+20,264
New +$2.18M 1.77% 18
2017
Q1 		– Sell
-400
Closed -$43K – 372
2016
Q4 		$43K Buy
+400
New +$47.7K 0.05% 143
2016
Q3 		– Sell
-10,779
Closed -$1.7M – 461
2016
Q2 		$1.54M Sell
10,779
-4,535
-30% -$661K 1.32% 16
2016
Q1 		$1.97M Buy
+15,314
New +$1.81M 2.06% 9

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

FT Options's ICPT Position: Q3 2017 in Review

FT Options opened a new position in Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2017: 20,264 shares worth $1.18M. The stake represents 1.77% of the portfolio and ranks #18 among its holdings. This is a return to the name: FT Options previously reported a position in ICPT as recently as Q4 2016.

FT Options first reported a position in ICPT in Q1 2016 and has held it in 4 quarters since. The position peaked at $1.97M in Q1 2016. 155 funds tracked by Wall St. Rank hold ICPT as of Q3 2017.

  • FT Options held 20,264 shares of Intercept Pharmaceuticals, Inc. worth $1.18M as of Q3 2017.
  • Intercept Pharmaceuticals, Inc. was a new FT Options position in Q3 2017.
  • Intercept Pharmaceuticals, Inc. made up 1.77% of FT Options's portfolio in Q3 2017, its #18 holding.
  • FT Options first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2016 and has held it in 4 quarters since.
  • FT Options's Intercept Pharmaceuticals, Inc. position peaked at $1.97M in Q1 2016.
  • 155 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2017.

Based on FT Options's 13F filing for Q3 2017, filed 13 Nov 2017.